We are live on
!
Find out more
JA
JLB & Associates Portfolio holdings
AUM
$696M
1-Year Est. Return
17.86%
This Fund
S&P 500
This Quarter
Est. Return
+15.12%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$628M
AUM Growth
+$63.8M
(+11%)
Cap. Flow
-$15.4M
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
33.96%
Holding
75
New
3
Increased
18
Reduced
50
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$259K |
| 2 |
KLA
KLAC
|
+$223K |
| 3 |
PRS
Prudential Financial Inc 5.625% Junior Subordinated Notes due 2058
PRS
|
+$215K |
| 4 |
FISV
Fiserv Inc
FISV
|
+$207K |
| 5 |
CBRE Group
CBRE
|
+$206K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.05M |
| 2 |
Apple
AAPL
|
+$879K |
| 3 |
T. Rowe Price
TROW
|
+$831K |
| 4 |
Copart
CPRT
|
+$753K |
| 5 |
Mastercard
MA
|
+$732K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.84% |
| 2 | Industrials | 18.82% |
| 3 | Healthcare | 16.3% |
| 4 | Financials | 16.23% |
| 5 | Consumer Discretionary | 15.59% |
Similar funds
AAM
CA
GUB
BBPWM
SCM
KLI
WIC
TCM
JLB & Associates's Q4 2022 Portfolio in Review
As of Q4 2022, JLB & Associates held 75 positions worth $628M, up 11% from $564M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
JLB & Associates's Q4 2022 filing shows 3 new, 18 increased, 50 reduced and 1 closed positions. Its largest new stake was Prudential Financial Inc 5.625% Junior Subordinated Notes due 2058: 9,042 shares worth $221K. The largest sale was Eli Lilly, an estimated $1.05M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Healthcare.
- JLB & Associates's largest Q4 2022 buy was Prudential Financial Inc 5.625% Junior Subordinated Notes due 2058: 9,042 shares worth $221K.
- JLB & Associates added most to Alphabet (Google) Class A in Q4 2022, an estimated $259K increase.
- JLB & Associates's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $1.05M.
- JLB & Associates's ten largest holdings make up 34% of its $628M portfolio in Q4 2022.
- JLB & Associates opened 3 new positions and closed 1 in Q4 2022.
- JLB & Associates's portfolio value rose 11% quarter-over-quarter to $628M.
Based on JLB & Associates's 13F filing for Q4 2022, filed 26 Jan 2023.